Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bayer posts fourth-quarter loss on Schering write-down
Bayer had recorded a profit of $211m in the same period of 2009, and analysts had forecast a 2010 fourth quarter profit of $219m, which did not come
Bayer had recorded a profit of $211m in the same period of 2009, and analysts had forecast a 2010 fourth quarter profit of $219m, which did not come
Daiichi will be paying $805m up-front with near-term milestone payments associated with the approval of Plexxikon’s melanoma treatment drug PLX4032 adding up to another $130m. The acquisition will
Infusion pumps are medical devices that deliver fluids, including nutrients and medications such as antibiotics, chemotherapy drugs, and pain relievers, into a patient’s body in controlled amounts and
The latest MediHoney line extension is dispensed from a tube and is comprised of Active Manuka (Leptospermum) honey blended with natural-based gelling agents. Derma Sciences president and CEO
The acquisition close follows the Letter of Intent executed on 22 December 2010, and the SPA announced on 23 February 2011. As previously reported, the consideration for the
Matrix Laboratories, a subsidiary of Mylan, claims Gabapentin capsules USP are the genereic version of Pfizer’s treatment for painful complication of shingles, Neurontin capsules. Gabapentin capsule is an
According to the company, the new application will help the researchers in improving accuracy while assessing drug safety and effectiveness, testing for drug interactions and developing new drugs.
The patent titled ‘Healthcare information management and communications system and method,’ application makes 104 separate claims. With the filing of the full utility patent, InstaCare plans to immediately
Leo Pharma has already executed installing Veeva CRM to its users in countries such as Hungary, Czech Republic, Slovakia, Poland, Romania, and Italy. Veeva Europe general manager Dan
Thermo Fisher Scientific vice president and general manager Verner Andersen said the acquisition of BD’s assets enables the company to provide continued availability of the product line to